GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXD4
|
ENSG00000170166.5 | homeobox D4 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_158787041 | 18.43 |
ENST00000471575.1
ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
chrX_-_13835147 | 15.70 |
ENST00000493677.1
ENST00000355135.2 |
GPM6B
|
glycoprotein M6B |
chrX_-_92928557 | 14.49 |
ENST00000373079.3
ENST00000475430.2 |
NAP1L3
|
nucleosome assembly protein 1-like 3 |
chrX_+_56590002 | 12.95 |
ENST00000338222.5
|
UBQLN2
|
ubiquilin 2 |
chr18_-_21891460 | 12.61 |
ENST00000357041.4
|
OSBPL1A
|
oxysterol binding protein-like 1A |
chr7_-_137028498 | 10.55 |
ENST00000393083.2
|
PTN
|
pleiotrophin |
chr14_+_90863327 | 9.87 |
ENST00000356978.4
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta) |
chr5_+_67586465 | 9.54 |
ENST00000336483.5
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chr1_+_84630645 | 9.48 |
ENST00000394839.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr17_-_73844722 | 9.46 |
ENST00000586257.1
|
WBP2
|
WW domain binding protein 2 |
chr7_-_137028534 | 9.39 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
chr9_-_93405352 | 8.97 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr15_+_84115868 | 8.61 |
ENST00000427482.2
|
SH3GL3
|
SH3-domain GRB2-like 3 |
chr17_-_29624343 | 8.28 |
ENST00000247271.4
|
OMG
|
oligodendrocyte myelin glycoprotein |
chr8_-_18871159 | 7.89 |
ENST00000327040.8
ENST00000440756.2 |
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr13_-_24007815 | 6.76 |
ENST00000382298.3
|
SACS
|
spastic ataxia of Charlevoix-Saguenay (sacsin) |
chr2_+_187371440 | 6.71 |
ENST00000445547.1
|
ZC3H15
|
zinc finger CCCH-type containing 15 |
chr16_-_29910853 | 6.56 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr3_+_111718173 | 6.53 |
ENST00000494932.1
|
TAGLN3
|
transgelin 3 |
chr8_-_102803163 | 6.25 |
ENST00000523645.1
ENST00000520346.1 ENST00000220931.6 ENST00000522448.1 ENST00000522951.1 ENST00000522252.1 ENST00000519098.1 |
NCALD
|
neurocalcin delta |
chr2_-_225434538 | 6.01 |
ENST00000409096.1
|
CUL3
|
cullin 3 |
chr5_+_140762268 | 5.91 |
ENST00000518325.1
|
PCDHGA7
|
protocadherin gamma subfamily A, 7 |
chr7_+_16793160 | 5.76 |
ENST00000262067.4
|
TSPAN13
|
tetraspanin 13 |
chr7_-_104909435 | 5.39 |
ENST00000357311.3
|
SRPK2
|
SRSF protein kinase 2 |
chr5_-_179499108 | 5.03 |
ENST00000521389.1
|
RNF130
|
ring finger protein 130 |
chr16_+_103816 | 4.84 |
ENST00000383018.3
ENST00000417493.1 |
SNRNP25
|
small nuclear ribonucleoprotein 25kDa (U11/U12) |
chr12_-_118628350 | 4.82 |
ENST00000537952.1
ENST00000537822.1 |
TAOK3
|
TAO kinase 3 |
chr17_+_66521936 | 4.74 |
ENST00000592800.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr9_+_470288 | 4.63 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr3_-_18480260 | 4.59 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr2_+_27886330 | 4.50 |
ENST00000326019.6
|
SLC4A1AP
|
solute carrier family 4 (anion exchanger), member 1, adaptor protein |
chr9_-_131790550 | 4.33 |
ENST00000372554.4
ENST00000372564.3 |
SH3GLB2
|
SH3-domain GRB2-like endophilin B2 |
chr11_-_77790865 | 4.17 |
ENST00000534029.1
ENST00000525085.1 ENST00000527806.1 ENST00000528164.1 ENST00000528251.1 ENST00000530054.1 |
NDUFC2
NDUFC2-KCTD14
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa NDUFC2-KCTD14 readthrough |
chr7_-_22233442 | 4.10 |
ENST00000401957.2
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr5_+_140743859 | 4.09 |
ENST00000518069.1
|
PCDHGA5
|
protocadherin gamma subfamily A, 5 |
chr17_-_78450398 | 4.09 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr1_-_101360331 | 4.06 |
ENST00000416479.1
ENST00000370113.3 |
EXTL2
|
exostosin-like glycosyltransferase 2 |
chr5_-_179499086 | 4.01 |
ENST00000261947.4
|
RNF130
|
ring finger protein 130 |
chr11_-_36310958 | 3.99 |
ENST00000532705.1
ENST00000263401.5 ENST00000452374.2 |
COMMD9
|
COMM domain containing 9 |
chr13_+_20207782 | 3.59 |
ENST00000414242.2
ENST00000361479.5 |
MPHOSPH8
|
M-phase phosphoprotein 8 |
chr2_-_166060552 | 3.51 |
ENST00000283254.7
ENST00000453007.1 |
SCN3A
|
sodium channel, voltage-gated, type III, alpha subunit |
chr7_+_101460882 | 3.35 |
ENST00000292535.7
ENST00000549414.2 ENST00000550008.2 ENST00000546411.2 ENST00000556210.1 |
CUX1
|
cut-like homeobox 1 |
chr1_+_67632083 | 3.31 |
ENST00000347310.5
ENST00000371002.1 |
IL23R
|
interleukin 23 receptor |
chr2_-_160473114 | 3.26 |
ENST00000392783.2
|
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
chr14_-_101036119 | 3.24 |
ENST00000355173.2
|
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr14_+_78174414 | 3.20 |
ENST00000557342.1
ENST00000238688.5 ENST00000557623.1 ENST00000557431.1 ENST00000556831.1 ENST00000556375.1 ENST00000553981.1 |
SLIRP
|
SRA stem-loop interacting RNA binding protein |
chr16_-_15736953 | 3.07 |
ENST00000548025.1
ENST00000551742.1 ENST00000602337.1 ENST00000344181.3 ENST00000396368.3 |
KIAA0430
|
KIAA0430 |
chr14_+_29236269 | 3.00 |
ENST00000313071.4
|
FOXG1
|
forkhead box G1 |
chr2_-_176046391 | 2.97 |
ENST00000392541.3
ENST00000409194.1 |
ATP5G3
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) |
chr2_-_207024233 | 2.96 |
ENST00000423725.1
ENST00000233190.6 |
NDUFS1
|
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) |
chr15_-_65809991 | 2.94 |
ENST00000559526.1
ENST00000358939.4 ENST00000560665.1 ENST00000321118.7 ENST00000339244.5 ENST00000300141.6 |
DPP8
|
dipeptidyl-peptidase 8 |
chr3_+_173116225 | 2.75 |
ENST00000457714.1
|
NLGN1
|
neuroligin 1 |
chr3_+_142342228 | 2.62 |
ENST00000337777.3
|
PLS1
|
plastin 1 |
chr17_-_7218631 | 2.61 |
ENST00000577040.2
ENST00000389167.5 ENST00000391950.3 |
GPS2
|
G protein pathway suppressor 2 |
chr2_-_166060571 | 2.54 |
ENST00000360093.3
|
SCN3A
|
sodium channel, voltage-gated, type III, alpha subunit |
chr15_+_80364901 | 2.32 |
ENST00000560228.1
ENST00000559835.1 ENST00000559775.1 ENST00000558688.1 ENST00000560392.1 ENST00000560976.1 ENST00000558272.1 ENST00000558390.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
chr5_-_78809950 | 2.31 |
ENST00000334082.6
|
HOMER1
|
homer homolog 1 (Drosophila) |
chr17_+_47448102 | 2.28 |
ENST00000576461.1
|
RP11-81K2.1
|
Uncharacterized protein |
chr1_-_87380002 | 2.25 |
ENST00000331835.5
|
SEP15
|
Homo sapiens 15 kDa selenoprotein (SEP15), transcript variant 2, mRNA. |
chr1_-_87379785 | 2.22 |
ENST00000401030.3
ENST00000370554.1 |
SEP15
|
Homo sapiens 15 kDa selenoprotein (SEP15), transcript variant 2, mRNA. |
chr12_+_16109519 | 2.19 |
ENST00000526530.1
|
DERA
|
deoxyribose-phosphate aldolase (putative) |
chr11_+_101983176 | 2.15 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr1_-_36948879 | 2.08 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr5_+_95066823 | 2.03 |
ENST00000506817.1
ENST00000379982.3 |
RHOBTB3
|
Rho-related BTB domain containing 3 |
chrX_-_10645773 | 2.01 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr21_-_27423339 | 1.97 |
ENST00000415997.1
|
APP
|
amyloid beta (A4) precursor protein |
chr11_-_104972158 | 1.97 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr17_-_50235423 | 1.94 |
ENST00000340813.6
|
CA10
|
carbonic anhydrase X |
chr5_+_141346385 | 1.94 |
ENST00000513019.1
ENST00000356143.1 |
RNF14
|
ring finger protein 14 |
chr3_-_149095652 | 1.92 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr10_-_50970322 | 1.84 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
chr18_+_32556892 | 1.82 |
ENST00000591734.1
ENST00000413393.1 ENST00000589180.1 ENST00000587359.1 |
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2 |
chr3_-_11623804 | 1.82 |
ENST00000451674.2
|
VGLL4
|
vestigial like 4 (Drosophila) |
chr12_+_12938541 | 1.78 |
ENST00000356591.4
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr16_+_84801852 | 1.77 |
ENST00000569925.1
ENST00000567526.1 |
USP10
|
ubiquitin specific peptidase 10 |
chr2_-_160472952 | 1.72 |
ENST00000541068.2
ENST00000355831.2 ENST00000343439.5 ENST00000392782.1 |
BAZ2B
|
bromodomain adjacent to zinc finger domain, 2B |
chr5_+_69321074 | 1.63 |
ENST00000380751.5
ENST00000380750.3 ENST00000503931.1 ENST00000506542.1 |
SERF1B
|
small EDRK-rich factor 1B (centromeric) |
chr10_+_18629628 | 1.62 |
ENST00000377329.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr19_+_48828788 | 1.61 |
ENST00000594198.1
ENST00000597279.1 ENST00000593437.1 |
EMP3
|
epithelial membrane protein 3 |
chr7_+_112063192 | 1.61 |
ENST00000005558.4
|
IFRD1
|
interferon-related developmental regulator 1 |
chr10_+_13652047 | 1.57 |
ENST00000601460.1
|
RP11-295P9.3
|
Uncharacterized protein |
chr13_+_37581115 | 1.55 |
ENST00000481013.1
|
EXOSC8
|
exosome component 8 |
chr3_-_149293990 | 1.46 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
chr10_+_48189612 | 1.38 |
ENST00000453919.1
|
AGAP9
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 |
chr19_+_48828582 | 1.31 |
ENST00000270221.6
ENST00000596315.1 |
EMP3
|
epithelial membrane protein 3 |
chr14_-_24911868 | 1.31 |
ENST00000554698.1
|
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr17_-_60142609 | 1.29 |
ENST00000397786.2
|
MED13
|
mediator complex subunit 13 |
chr15_-_55700457 | 1.18 |
ENST00000442196.3
ENST00000563171.1 ENST00000425574.3 |
CCPG1
|
cell cycle progression 1 |
chr4_-_143227088 | 1.18 |
ENST00000511838.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr1_+_144146808 | 1.16 |
ENST00000369190.5
ENST00000412624.2 ENST00000369365.3 |
NBPF8
|
neuroblastoma breakpoint family, member 8 |
chr1_-_120935894 | 1.09 |
ENST00000369383.4
ENST00000369384.4 |
FCGR1B
|
Fc fragment of IgG, high affinity Ib, receptor (CD64) |
chr3_+_197518100 | 1.08 |
ENST00000438796.2
ENST00000414675.2 ENST00000441090.2 ENST00000334859.4 ENST00000425562.2 |
LRCH3
|
leucine-rich repeats and calponin homology (CH) domain containing 3 |
chr14_-_24911971 | 1.04 |
ENST00000555365.1
ENST00000399395.3 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr2_+_204571375 | 0.99 |
ENST00000374478.4
|
CD28
|
CD28 molecule |
chr6_-_87804815 | 0.97 |
ENST00000369582.2
|
CGA
|
glycoprotein hormones, alpha polypeptide |
chr5_-_55412774 | 0.96 |
ENST00000434982.2
|
ANKRD55
|
ankyrin repeat domain 55 |
chr16_+_24549014 | 0.94 |
ENST00000564314.1
ENST00000567686.1 |
RBBP6
|
retinoblastoma binding protein 6 |
chr5_+_179921344 | 0.91 |
ENST00000261951.4
|
CNOT6
|
CCR4-NOT transcription complex, subunit 6 |
chr5_+_52083730 | 0.86 |
ENST00000282588.6
ENST00000274311.2 |
ITGA1
PELO
|
integrin, alpha 1 pelota homolog (Drosophila) |
chr15_+_64386261 | 0.83 |
ENST00000560829.1
|
SNX1
|
sorting nexin 1 |
chr1_-_190446759 | 0.83 |
ENST00000367462.3
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
chr12_+_112279782 | 0.82 |
ENST00000550735.2
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5 |
chr4_-_143226979 | 0.81 |
ENST00000514525.1
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr7_+_55433131 | 0.81 |
ENST00000254770.2
|
LANCL2
|
LanC lantibiotic synthetase component C-like 2 (bacterial) |
chr15_-_55700522 | 0.81 |
ENST00000564092.1
ENST00000310958.6 |
CCPG1
|
cell cycle progression 1 |
chr12_+_21168630 | 0.80 |
ENST00000421593.2
|
SLCO1B7
|
solute carrier organic anion transporter family, member 1B7 (non-functional) |
chr16_-_21663919 | 0.78 |
ENST00000569602.1
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr2_+_109237717 | 0.75 |
ENST00000409441.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr12_-_49245936 | 0.74 |
ENST00000308025.3
|
DDX23
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 |
chr15_-_56209306 | 0.67 |
ENST00000506154.1
ENST00000338963.2 ENST00000508342.1 |
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
chr12_+_9980113 | 0.66 |
ENST00000537723.1
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1 |
chr18_-_61311485 | 0.65 |
ENST00000436264.1
ENST00000356424.6 ENST00000341074.5 |
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
chr5_-_10761206 | 0.54 |
ENST00000432074.2
ENST00000230895.6 |
DAP
|
death-associated protein |
chrX_+_70752917 | 0.51 |
ENST00000373719.3
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase |
chr2_-_99279928 | 0.49 |
ENST00000414521.2
|
MGAT4A
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
chr2_+_170440844 | 0.49 |
ENST00000260970.3
ENST00000433207.1 ENST00000409714.3 ENST00000462903.1 |
PPIG
|
peptidylprolyl isomerase G (cyclophilin G) |
chr1_+_87380299 | 0.47 |
ENST00000370551.4
ENST00000370550.5 |
HS2ST1
|
heparan sulfate 2-O-sulfotransferase 1 |
chr6_+_46761118 | 0.44 |
ENST00000230588.4
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase) |
chr4_-_46996424 | 0.43 |
ENST00000264318.3
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
chr3_+_69812877 | 0.43 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
chr18_-_19283649 | 0.41 |
ENST00000584464.1
ENST00000578270.1 |
ABHD3
|
abhydrolase domain containing 3 |
chr7_+_77428149 | 0.38 |
ENST00000415251.2
ENST00000275575.7 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr17_-_41132410 | 0.37 |
ENST00000409446.3
ENST00000453594.1 ENST00000409399.1 ENST00000421990.2 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
chr1_+_197237352 | 0.35 |
ENST00000538660.1
ENST00000367400.3 ENST00000367399.2 |
CRB1
|
crumbs homolog 1 (Drosophila) |
chr1_+_115572415 | 0.26 |
ENST00000256592.1
|
TSHB
|
thyroid stimulating hormone, beta |
chr2_+_234590556 | 0.24 |
ENST00000373426.3
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7 |
chr14_-_99947168 | 0.24 |
ENST00000331768.5
|
SETD3
|
SET domain containing 3 |
chr2_+_234826016 | 0.22 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
chr3_+_51575596 | 0.22 |
ENST00000409535.2
|
RAD54L2
|
RAD54-like 2 (S. cerevisiae) |
chr18_-_19994830 | 0.20 |
ENST00000525417.1
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1 |
chr13_+_33160553 | 0.19 |
ENST00000315596.10
|
PDS5B
|
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
chr1_-_231560790 | 0.19 |
ENST00000366641.3
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1 |
chr2_+_196313239 | 0.17 |
ENST00000413290.1
|
AC064834.1
|
AC064834.1 |
chr5_-_137475071 | 0.17 |
ENST00000265191.2
|
NME5
|
NME/NM23 family member 5 |
chr2_+_166095898 | 0.15 |
ENST00000424833.1
ENST00000375437.2 ENST00000357398.3 |
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
chr6_-_44281043 | 0.14 |
ENST00000244571.4
|
AARS2
|
alanyl-tRNA synthetase 2, mitochondrial |
chr6_+_53659746 | 0.10 |
ENST00000370888.1
|
LRRC1
|
leucine rich repeat containing 1 |
chr7_+_77428066 | 0.09 |
ENST00000422959.2
ENST00000307305.8 ENST00000424760.1 |
PHTF2
|
putative homeodomain transcription factor 2 |
chr12_-_112279694 | 0.07 |
ENST00000443596.1
ENST00000442119.1 |
MAPKAPK5-AS1
|
MAPKAPK5 antisense RNA 1 |
chr20_+_32150140 | 0.02 |
ENST00000344201.3
ENST00000346541.3 ENST00000397800.1 ENST00000397798.2 ENST00000492345.1 |
CBFA2T2
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 19.9 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
3.2 | 13.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.9 | 9.5 | GO:0097338 | response to clozapine(GO:0097338) |
1.6 | 15.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.5 | 4.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
1.5 | 6.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.4 | 2.7 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
1.4 | 9.5 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
1.1 | 5.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.0 | 4.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 3.3 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.8 | 3.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.8 | 2.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.6 | 9.5 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.5 | 1.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.5 | 2.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 2.0 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 6.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 4.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 2.0 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.4 | 7.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 2.0 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.4 | 1.5 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.4 | 2.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 4.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 4.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 1.6 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.3 | 3.6 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.7 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.2 | 10.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 4.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.7 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.2 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 2.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 8.3 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 14.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 5.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.8 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 3.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 2.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 3.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 2.3 | GO:0072663 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.8 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 1.0 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.1 | 4.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 2.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 1.5 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 5.3 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 1.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 1.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 1.8 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.2 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 1.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 2.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 2.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 3.4 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 1.0 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.0 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 1.8 | GO:0051301 | cell division(GO:0051301) |
0.0 | 0.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.8 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 3.5 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.2 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.0 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 2.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.9 | GO:0061053 | somite development(GO:0061053) |
0.0 | 0.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 4.8 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 10.4 | GO:0007417 | central nervous system development(GO:0007417) |
0.0 | 9.0 | GO:0016567 | protein ubiquitination(GO:0016567) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 9.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
1.0 | 6.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 3.3 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.7 | 14.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 6.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 3.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.4 | 2.6 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 2.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.4 | 6.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 2.0 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.4 | 6.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 0.9 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.3 | 1.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 3.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 21.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 4.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 2.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 3.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 1.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 13.0 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 4.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 12.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 1.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 4.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 9.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 9.9 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 8.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 10.6 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 2.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 15.9 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 3.4 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 1.3 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 6.2 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 6.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 1.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 7.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.8 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 3.7 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 6.6 | GO:0042175 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 19.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.5 | 6.0 | GO:0031208 | POZ domain binding(GO:0031208) |
1.2 | 9.5 | GO:0043559 | insulin binding(GO:0043559) |
0.8 | 3.3 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.8 | 4.1 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.7 | 2.2 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.6 | 9.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 2.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.4 | 2.0 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.4 | 1.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.4 | 12.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.3 | 6.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 4.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 7.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 6.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 4.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 2.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 2.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 6.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 5.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 9.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 2.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 3.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 2.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 3.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 3.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 5.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 4.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 2.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 10.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 2.5 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 2.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 4.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 9.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 13.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 10.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 8.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 1.2 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 3.5 | GO:0016491 | oxidoreductase activity(GO:0016491) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 19.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 9.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 9.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 6.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 4.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 9.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 2.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 3.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 3.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 16.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 9.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 14.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 3.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 1.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 3.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 12.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 8.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 4.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 7.7 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.7 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |